维普期刊资源整合服务平台（V6.5）

52篇 您的检索式：作者名="CASTAGNETTI F"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Overexpansion technique inburn scar management显示文摘	Di MD Castagnetti F Mazzeo F	2006	Burns2006，32，4：	1
2	Anterior abrasion of earcartilage with dermablader显示文摘	Di cio D Castagnetti F Baldassarre S	2003	Aesthet Plast Surg2003，27，6：	1
3	Chro- nic myeloid leukemia (CML) patients with ' suboptimal' re- sponse to imatinib (IM) according to european leukemia net cri- teria have a poorer outcome with respect to 'optimal' responders: a GIMEMA CML WORKING PARTY analysis显示文摘	CASTAGNETTI F GUGLIOTTA G PALANDRI F	2009	Blood2009，114，：	1
4	Tubed flap interpolation in reconstruction of helical and ear lobe defects显示文摘	Di Mascio D Castagnetti F	2004	Dermatol Surg2004，30，41：	1
5	Chronic myeloid leukemia (CML) patients with 'suboptimal” response to imatinib (IM) according to European LeukemiaNet criteria have a poorer outcome with respect to 'optimal” responders:a GIMEMA CML working party analysis显示文摘	Castagnetti F Gugliotta G Palandri F	2009	{H}Blood2009，，22：	1
6	Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate:GIMEMA CML working party analysis显示文摘	Castagnetti F Testoni N Luatti S	2010	J Clin Oncol2010，28，16：	1
7	The long-term dura- bility of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up 显示文摘	Palandri F Castagnetti F Alimena G	2009	Haematologica2009，94，2：	1
8	Frontline imatinib treatment of chronic myeloid leukemia: no impact of age on outcome, a survey by the GIMEMA CML Working Party显示文摘	Gugliotta G Castagnetti F Palandri F	2011	Blood2011，117，21：	1
9	The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase 显示文摘	Palandri F Castagnetti F Iacobucci I	2010	Haematologiea2010，95，14：	1
10	Dasatinib and nilotinib in imatinib-resistant Philadelphia-positive chronic myelogenous leu- kemia: a 'head-to-head eomparison'显示文摘	Rosti G Castagnetti F Gugliotta G	2010	Leuk Lymphoma2010，51，4：	1
11	Nilotinib for the frontline treatment of Ph (+) chronic myeloid leukemia显示文摘	Rosti G Palandri F Castagnetti F	2009	Blood2009，114，24：	1
12	Tubed flap interpolation in recon- struction of helical and ear lobe defects 显示文摘	Di Mascio D Castagnetti F	2004	Dermatol Surg2004，30，4：	1
13	Early diagnosis of melanoma-what is the impact of dermoscopy显示文摘	Argenziano G Albertini G Castagnetti F	2012	Dermatol Ther2012，25，5：	1
14	European Leukemia netresponse definitions and European \|eukemianet management rec- ommendations 显示文摘	Baccarani M Castagnetti F Gugliotta G	2009	Best Pract Res Clin Haematol2009，22，3：	1
15	Second-generation BCR-ABL inhibitors for frontline treatment of chronic myeloid leukemia in chronic phase 显示文摘	Rosti G Castagnetti F Gugliotta G	2012	Oncology Hematology2012，82，：	1
16	Results of high-dose imatinib mesylate in intermediate Sokal risk chronic myeloid leukemia patients in early chronic phase:a phase 2 trial of the GIME-MA CML Working Party显示文摘	Castagnetti F Palandri F Amabile M	2009	Blood2009，113，15：	1
17	Nilotinib for the front- line treatment of Ph + chronic myeloid leukemia 显示文摘	Rosti G Palandri F Castagnetti F et ai	2009	Blood2009，114，24：	1
18	First-Line treatment of newly diagnosed elderly patients with chronic myeloid leukemia:current and emerging strategies显示文摘	Gugliotta G Castagnetti F Apolinari MA	2014	Drugs2014，74，6：	1
19	Indirect comparisons of second-generation tyrosine kinase inhibitors in CML: case study using baseline population characteristics 显示文摘	Carpiuc K T Rosti G Castagnetti F	2010	Onco Targets Ther2010，3，：	1
20	The long-term durability of eytogenetic responses in patients with accel- erated phase chronic myeloid leukemia treated with ima- tinib 600 mg:the GIMEMA CML Working Party experi- ence after a 7-year follow-up显示文摘	Palandri F Castagnetti F Alimena G	2009	Haematologica2009，94，2：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示